NAT10 and hepatocellular carcinoma: The expression of NAT10 in patients with HCC complicated with hepatitis B and cirrhosis was significantly higher than that in patients with HCC alone (Z = −2.433, P = 0.015), but not significantly associated with other factors (Table 1).